Origin Protocol / Turkey Lira
3.092
06-November-24 08:28:18
realtime
Instruments
-0.028
-0.90%
Today's range
2.999 - 3.274
ISIN
FXOGNTRY
Source
BINCE
-
Trimble (NASDAQ:TRMB) Releases FY 2024 Earnings Guidance
06 Nov 2024 07:48:16 By Buzz FX
-
Needham & Company LLC Reiterates Buy Rating for CRISPR Therapeutics (NASDAQ:CRSP)
06 Nov 2024 07:48:16 By Buzz FX
-
Broadridge Financial Solutions (NYSE:BR) Given New $207.00 Price Target at Morgan Stanley
06 Nov 2024 07:48:16 By Buzz FX
-
Needham & Company LLC Cuts Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $60.00
06 Nov 2024 07:48:16 By Buzz FX
-
Northern Dynasty Minerals (NYSEAMERICAN:NAK) Price Target Raised to $1.30 at HC Wainwright
06 Nov 2024 07:48:16 By Buzz FX
-
OptimizeRx (OPRX) Scheduled to Post Quarterly Earnings on Wednesday
06 Nov 2024 07:48:16 By Buzz FX
-
Robert W. Baird Boosts Revolve Group (NYSE:RVLV) Price Target to $33.00
06 Nov 2024 07:48:16 By Buzz FX
-
POLAND: NBP Leave Rates Unchanged, As Expected
06 Nov 2024 07:47:29 By Buzz FX
-
HC Wainwright Reaffirms "Buy" Rating for Kura Oncology (NASDAQ:KURA)
06 Nov 2024 07:47:17 By Buzz FX
-
Inozyme Pharma's (INZY) "Buy" Rating Reiterated at HC Wainwright
06 Nov 2024 07:47:17 By Buzz FX
-
HC Wainwright Cuts Century Therapeutics (NASDAQ:IPSC) Price Target to $5.00
06 Nov 2024 07:47:17 By Buzz FX
-
MacroGenics' (MGNX) "Neutral" Rating Reiterated at HC Wainwright
06 Nov 2024 07:47:17 By Buzz FX
-
Robert W. Baird Issues Positive Forecast for Illumina (NASDAQ:ILMN) Stock Price
06 Nov 2024 07:47:17 By Buzz FX
-
Stoke Therapeutics (NASDAQ:STOK) Given Buy Rating at Needham & Company LLC
06 Nov 2024 07:47:17 By Buzz FX
-
Nurix Therapeutics' (NRIX) Buy Rating Reaffirmed at Needham & Company LLC
06 Nov 2024 07:47:17 By Buzz FX
-
Qualys (NASDAQ:QLYS) Price Target Raised to $126.00 at Morgan Stanley
06 Nov 2024 07:47:17 By Buzz FX
-
06 Nov 2024 07:47:17 By Buzz FX
-
MercadoLibre, Inc. (NASDAQ:MELI) Stock Holdings Decreased by Hardman Johnston Global Advisors LLC
06 Nov 2024 07:47:17 By Buzz FX
-
Equities Analysts Issue Forecasts for Clorox FY2026 Earnings
06 Nov 2024 07:47:17 By Buzz FX
-
Needham & Company LLC Reaffirms "Buy" Rating for Inozyme Pharma (NASDAQ:INZY)
06 Nov 2024 07:47:17 By Buzz FX